Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis

OBJECTIVES: This study aims to determine whether baseline body mass index (BMI) affects clinical response to tocilizumab (TCZ) after six months of treatment in rheumatoid arthritis (RA) patients. PATIENTS AND METHODS: In this prospective study, a total of 52 RA patients (10 males, 42 females; mean a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arch Rheumatol
Main Authors: HUANG, Hua, CEN, Han, ZHOU, Li, WANG, Ting-hui, QIN, Wen, XIE, Bin-hua, XIAO, Dong-Mei, WU, Xiu-Di, WU, Hua-Xiang
Formato: Artigo
Idioma:Inglês
Publicado: Turkish League Against Rheumatism 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6974388/
https://ncbi.nlm.nih.gov/pubmed/32010889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5606/ArchRheumatol.2019.7146
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares